In the current global market landscape, investors are navigating a complex environment marked by steady interest rates and mixed economic indicators, with U.S. stocks showing resilience despite ...

A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...

Animal fat grown in a bioreactor could be heading to Japan following a partnership between UK-based Hoxton Farms and Japan’s ...

Intellectual property law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Liliana Di Nola-Baron, Ph.D. has joined the firm as Counsel. Her practice encompasses drafting and ...

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 ...

Amid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Magnificent Seven’ of ASX drug ...

Shawn Roehrig, owner of Roland’s Paint and More, has seen major improvements in his battle with lung and brain cancer, ...

Jau Bhattacharya, who is an Indian-origin professor at Stanford School of Medicine, is confirmed as the Director of NIH.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Ryoncil ® (remestemcel-L) the first mesenchymal stromal cell ...

You already have NAD+. A coenzyme in your body, it is key to powering energy metabolism, DNA repair, circadian rhythm ...